GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (OSTO:NANOo) » Definitions » Loans Receivable

Thor Medical ASA (OSTO:NANOO) Loans Receivable : kr0.00 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA Loans Receivable?

Thor Medical ASA's Loans Receivable for the quarter that ended in Dec. 2023 was kr0.00 Mil.


Thor Medical ASA Loans Receivable Historical Data

The historical data trend for Thor Medical ASA's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thor Medical ASA Loans Receivable Chart

Thor Medical ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Thor Medical ASA Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Jun23 Dec23
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Thor Medical ASA Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Thor Medical ASA Loans Receivable Related Terms

Thank you for viewing the detailed overview of Thor Medical ASA's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Thor Medical ASA (OSTO:NANOO) Business Description

Traded in Other Exchanges
Address
Kjelsasveien 168 B, Oslo, NOR, 0884
Nordic Nanovector ASA is a biopharmaceutical company. It is engaged in the development and commercialization of targeted therapeutics to improve the lives of patients with haematological cancers, such as non-Hodgkin lymphoma and leukaemia. The company's main clinical stage product is Betalutin.

Thor Medical ASA (OSTO:NANOO) Headlines

No Headlines